Yang J - Search Results

1

Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy.

Wang-Bishop L, Wehbe M, Pastora LE, Yang J, Kimmel BR, Garland KM, Becker KW, Carson CS, Roth EW, Gibson-Corley KN, Ulkoski D, Krishnamurthy V, Fedorova O, Richmond A, Pyle AM, Wilson JT. Wang-Bishop L, et al. Among authors: yang j. ACS Nano. 2024 May 7;18(18):11631-11643. doi: 10.1021/acsnano.3c06225. Epub 2024 Apr 23. ACS Nano. 2024. PMID: 38652829 Free PMC article.

2

How do chemokine/chemokine receptor activations affect tumorigenesis?

Richmond A, Fan GH, Dhawan P, Yang J. Richmond A, et al. Among authors: yang j. Novartis Found Symp. 2004;256:74-89; discussion 89-91, 106-11, 266-9. Novartis Found Symp. 2004. PMID: 15027484 Review.

3

The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan.

Yang J, Richmond A. Yang J, et al. Mol Ther. 2004 Jun;9(6):846-55. doi: 10.1016/j.ymthe.2004.01.010. Mol Ther. 2004. PMID: 15194051 Free PMC article.

4

BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways.

Yang J, Amiri KI, Burke JR, Schmid JA, Richmond A. Yang J, et al. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):950-60. doi: 10.1158/1078-0432.CCR-05-1220. Clin Cancer Res. 2006. PMID: 16467110 Free PMC article.

5

Antioxidants tiron and N-acetyl-L-cysteine differentially mediate apoptosis in melanoma cells via a reactive oxygen species-independent NF-kappaB pathway.

Yang J, Su Y, Richmond A. Yang J, et al. Free Radic Biol Med. 2007 May 1;42(9):1369-80. doi: 10.1016/j.freeradbiomed.2007.01.036. Epub 2007 Jan 30. Free Radic Biol Med. 2007. PMID: 17395010 Free PMC article.

6

Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth.

Yang J, Pan WH, Clawson GA, Richmond A. Yang J, et al. Cancer Res. 2007 Apr 1;67(7):3127-34. doi: 10.1158/0008-5472.CAN-06-3547. Cancer Res. 2007. PMID: 17409419 Free PMC article.

7

The good and the bad of chemokines/chemokine receptors in melanoma.

Richmond A, Yang J, Su Y. Richmond A, et al. Among authors: yang j. Pigment Cell Melanoma Res. 2009 Apr;22(2):175-86. doi: 10.1111/j.1755-148X.2009.00554.x. Epub 2009 Feb 14. Pigment Cell Melanoma Res. 2009. PMID: 19222802 Free PMC article. Review.

8

Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy.

Yang J, Zaja-Milatovic S, Thu YM, Lee F, Smykla R, Richmond A. Yang J, et al. Mol Cancer Ther. 2009 Mar;8(3):636-47. doi: 10.1158/1535-7163.MCT-08-0749. Epub 2009 Mar 10. Mol Cancer Ther. 2009. PMID: 19276165 Free PMC article.

9

Monitoring NF-kappaB mediated chemokine transcription in tumorigenesis.

Yang J, Richmond AJ. Yang J, et al. Methods Enzymol. 2009;460:347-55. doi: 10.1016/S0076-6879(09)05217-3. Methods Enzymol. 2009. PMID: 19446734 Free PMC article.

10

Conditional ablation of Ikkb inhibits melanoma tumor development in mice.

Yang J, Splittgerber R, Yull FE, Kantrow S, Ayers GD, Karin M, Richmond A. Yang J, et al. J Clin Invest. 2010 Jul;120(7):2563-74. doi: 10.1172/JCI42358. Epub 2010 Jun 7. J Clin Invest. 2010. PMID: 20530876 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85,647 results

Search Page